Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on NIGHTHAWK ENERGY PLC. We currently have 8 research reports from 2 professional analysts.
|15Mar17 07:00||RNS||Notice of GM - Rule 9 Waiver|
|15Feb17 07:00||RNS||Update re Operations and Year-end Reserves|
|26Jan17 07:00||RNS||Correction - Production Update|
|24Jan17 07:00||RNS||Production Update|
|18Jan17 16:35||RNS||Price Monitoring Extension|
|12Jan17 07:00||RNS||Operations Update|
|03Jan17 07:00||RNS||Company Update|
Frequency of research reports
Research reports on
NIGHTHAWK ENERGY PLC
NIGHTHAWK ENERGY PLC
Waiver of Rule 9
14 Mar 17
Nighthawk is asking independent shareholders to approve a waiver of Rule 9 of the City Code in order to settle deferred cash interest on renegotiated loan notes held by major shareholder, Johan Claesson, in shares. Payment in shares would allow the company to preserve working capital as it seeks to complete the ongoing Waterflood Pilot Project. We think that this is in the best interests of all shareholders. A measureable response from the Pilot Project should be reported in Q2 2017. We reiterate our Buy rating and 7p target price.
Small Cap Breakfast
15 Feb 17
Xafinity –Publication of prospectus. The pensions actuarial, consulting and administration business has conditionally raised £179.6m. At 139p. Due to join main market 16 Feb. Guinness Oil & Gas Exploration—Publication of prospectus. Seeking to raise £50m and invest in 15 exploration companies at launch, with plans to grow the portfolio to 30 positions during its lifetime. Issue closing 23 Feb. Arix Bioscience — Intention to float on the main market from the global healthcare and life science company supporting medical innovation. Raised £52m in Feb 16 with investors including Woodford Investment Management
Funded to initiate Waterflood Pilot
04 Aug 16
We maintain our Buy rating on Nighthawk Energy and 7p target price following encouraging recent developments, particularly on funding and progress with the Arikaree Creek Waterflood Pilot project, which demonstrate the strong support of existing shareholders and the quality of the underlying assets. Nighthawk has an attractive portfolio of low-cost, conventional production and development assets in the Denver-Julesberg basin, one of the more underdeveloped hydrocarbon provinces remaining onshore US.
03 Feb 16
We reiterate our Buy rating and revise our target price to 7p following the recent production and revenue guidance update. Nighthawk has endured a challenging few months with poor drilling results from its Monarch JV assets and a reduction in its RBL borrowing base. Its near-term focus on operational efficiency and cash preservation should however set the company up well to take advantage of its low cost, high return conventional production and development assets as the macro-environment improves through 2016.
RBL redetermination not an issue
04 Nov 15
We reiterate our Buy rating and retain our 12.5p price target following news of a redetermination of the borrowing base under the RBL the company has with the Commonwealth Bank of Australia. Nighthawk as adequate liquid funds to meet potential repayments and to fund the remaining wells under the 2015 drilling programme. As we highlighted in our recent note “A turning point for the E&P sector”, we are positive on oil and the E&P sector and would buy into any weakness in the share price on the back of this news.
Oil & Gas - A turning point for the E&P sector
28 Oct 15
We suggest that, following 4½ years of underperformance, the E&P sector is set for a sharp recovery relative to the market. We think that this will be driven by a dramatic reversal in E&P margins, as a recovery in oil prices coincides with reductions in upstream costs, similar to what happened in 2003/04 (following the consolidation of the majors) and 2009/10 (post the financial crisis). We focus our stock recommendations on our corporate clients – Andes Energia, Nighthawk Energy and Oilex - but acknowledge that the entire sector should participate in the recovery.
27 Mar 17
Elecosoft* (ELCO): Steadily building profits (CORP) | Bioventix* (BVXP): Interim results lead to upgrades (CORP) | Hurricane Energy (HUR): Halifax discovery (BUY) | KBT Business Technology* (KBT): interims and contract win (CORP) | Independent Oil & Gas* (IOG): Licence updates (CORP)
Strong trading leads to upgrades
22 Mar 17
On the back of today’s positive trading update and slightly upgraded profit forecasts for FY2017, FY2018 and FY2019 we have reviewed our DCF analysis. This has led to an increased DCF valuation per share of 1500p (from 1200p) which we have made our new target price (from 1200p). Both TFP and JC Paper have contributed to the upgrades shown in the table below as have favourable currency movements. With the potential for further upgrades due to capitalising 3DP costs to come we maintain our Add recommendation.
GMP FirstEnergy ― UK Energy morning research package
27 Mar 17
Amerisur Resources (AMER LN)6; HOLD, £0.30: Reduced 2017e production outlook and year-end 2016 reserves | Condor Petroleum (CPI CN)8 ; BUY, C$3.50: Reports 4Q16 results and remains on track for first production from Turkey in mid-2017e | Hurricane Energy (HUR LN) (not covered): Halifax well update in the UK | Cairn Energy (CNE LN): BUY, £2.90: Update on the VR-1 well in Senegal by Far (FAR AU) (Not covered) | Royal Dutch Shell (RDSA/B LN) (not covered): Divestment of Gabonese assets
Small Cap Breakfast
21 Mar 17
First Sentinel—Investment company expecting NEX admission/introduction on 24 March. £636k raised pre-IPO. BioPharma Credit—Expected Gross Initial Acquisition Proceeds now c.$338m. Gross Cash Proceeds capped at $423m with placing and open offer. Results expected 23 March with admission now due 30 march. Tufton Oceanic Assets- The Company intends to invest in a diversified portfolio of second hand commercial sea-going vessels where the Investment Manager believes that an attractive opportunity exists in shipping. $150m raise. Admission 3 April.